Cargando…

Outbreak response strategies with type 2-containing oral poliovirus vaccines ()

Despite exhaustive and fully-financed plans to manage the risks of globally coordinated cessation of oral poliovirus vaccine (OPV) containing type 2 (OPV2) prior to 2016, as of 2022, extensive, continued transmission of circulating vaccine-derived polioviruses (cVDPVs) type 2 (cVDPV2) remains. Notab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalkowska, Dominika A., Wassilak, Steven G.F., Pallansch, Mark A., Burns, Cara C., Wiesen, Eric, Durry, Elias, Badizadegan, Kamran, Thompson, Kimberly M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284582/ https://www.ncbi.nlm.nih.gov/pubmed/36402659 http://dx.doi.org/10.1016/j.vaccine.2022.10.060

Ejemplares similares

Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation
por: Kalkowska, Dominika A, et al.
Publicado: (2023)

Looking back at prospective modeling of outbreak response strategies for managing global type 2 oral poliovirus vaccine (OPV2) cessation
por: Thompson, Kimberly M., et al.
Publicado: (2023)

A Health Economic Analysis for Oral Poliovirus Vaccine to Prevent COVID‐19 in the United States
por: Thompson, Kimberly M., et al.
Publicado: (2020)

The impact of disruptions caused by the COVID-19 pandemic on global polio eradication()
por: Kalkowska, Dominika A., et al.
Publicado: (2023)

Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination
por: Kalkowska, Dominika A, et al.
Publicado: (2015)

Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021
por: Alleman, Mary M., et al.
Publicado: (2021)

Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, July 2019–February 2020
por: Alleman, Mary M., et al.
Publicado: (2020)

Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV)
por: Thompson, Kimberly M., et al.
Publicado: (2019)

Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the Global Polio Eradication Initiative
por: Thompson, Kimberly M., et al.
Publicado: (2022)

Polio by the Numbers—A Global Perspective( )
por: Badizadegan, Kamran, et al.
Publicado: (2022)

Health economic analysis of antiviral drugs in the global polio eradication endgame
por: Badizadegan, Kamran, et al.
Publicado: (2023)

Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2018–June 2019
por: Jorba, Jaume, et al.
Publicado: (2019)

Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020()
por: Darwar, Roopa, et al.
Publicado: (2023)

An economic analysis of poliovirus risk management policy options for 2013–2052
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

Potential Future Use, Costs, and Value of Poliovirus Vaccines
por: Thompson, Kimberly M., et al.
Publicado: (2020)

Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame
por: Thompson, Kimberly M., et al.
Publicado: (2020)

The potential impact of expanding target age groups for polio immunization campaigns
por: Duintjer Tebbens, Radboud J, et al.
Publicado: (2014)

Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication
por: Thompson, Kimberly M., et al.
Publicado: (2020)

Updated modelling of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters
por: Kalkowska, D. A., et al.
Publicado: (2019)

Another look at silent circulation of poliovirus in small populations
por: Kalkowska, Dominika A., et al.
Publicado: (2018)

Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population
por: Wassilak, Steven, et al.
Publicado: (2011)

Global certification of wild poliovirus eradication: insights from modelling hard-to-reach subpopulations and confidence about the absence of transmission
por: Duintjer Tebbens, Radboud J, et al.
Publicado: (2019)

Update on Vaccine-Derived Poliovirus Outbreaks — Democratic Republic of the Congo and Horn of Africa, 2017–2018
por: Mbaeyi, Chukwuma, et al.
Publicado: (2019)

Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal()
por: Harutyunyan, Vachagan, et al.
Publicado: (2023)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2016–June 2017
por: Jorba, Jaume, et al.
Publicado: (2017)

Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2021–December 2022
por: Bigouette, John Paul, et al.
Publicado: (2023)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2017–June 2018
por: Jorba, Jaume, et al.
Publicado: (2018)

Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2016)

Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2017)

Update on Vaccine-Derived Polioviruses — Worldwide, July 2012–December 2013
por: Diop, Ousmane M., et al.
Publicado: (2014)

Progress Toward Poliovirus Containment Implementation — Worldwide, 2019–2020
por: Moffett, Daphne B., et al.
Publicado: (2020)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2014–March 2015
por: Diop, Ousmane M., et al.
Publicado: (2015)

Notes from the Field: CDC Polio Surge Response to Expanding Outbreaks of Type 2 Circulating Vaccine-Derived Poliovirus — Africa and Philippines, September 2019–March 2020
por: Meyer, Erika, et al.
Publicado: (2020)

Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States
por: Marin, Mona, et al.
Publicado: (2017)

How should we prepare for an outbreak of reintroduced live polioviruses?
por: Thompson, Kimberly M, et al.
Publicado: (2017)

The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
por: Thompson, Kimberly M., et al.
Publicado: (2015)

Emergence of Vaccine-derived Polioviruses, Democratic Republic of Congo, 2004–2011
por: Gumede, Nicksy, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v4lf7juscd6rjb0rjm7potnt7l